Curaleaf Holdings, Inc. is the holding company of Curaleaf Inc., a vertically integrated cannabis operator with dispensaries, cultivation sites and processing sites in the United States.
PalliaTech, Inc. was founded in 2010 and changed its name to Curaleaf, Inc. in 2018.
301 Edgewater Place, Suite 405
Wakefield, MA 01880
Meet our management team.
Curaleaf is incorporated in the state of Delaware.
Curaleaf became a wholly-owned subsidiary of Curaleaf Holdings, Inc., a publicly traded company through a reverse takeover, or RTO, on October 29, 2018.
A reverse takeover (RTO), or a reverse merger, is a type of merger whereby a private company merges with a publicly listed “shell,” resulting in the shares of the private company being exchange for publicly traded shares of the listing holding company. It is a common avenue for accessing the Canadian capital markets.
Curaleaf Holdings, Inc. stock trades on the Canadian Securities Exchange under the ticker symbol “CURA”.
Our public securities filings are available on www.sedar.com.
Our stock can be purchased by contacting a registered stock broker or through an online stock brokerage service for self-directed investors.
Yes, non-Canadian residents can invest in Curaleaf. Please consult your broker to determine whether they are able to execute on your behalf on the Canadian Securities Exchange.
No, but Curaleaf stock can be purchased through a brokerage firm, including online brokerage services.
At this time, Curaleaf does not offer a direct stock purchase plan.
At this time, Curaleaf does not pay a dividend.
Curaleaf's fiscal year ends on December 31.
The cusip for Curaleaf is 23126M102.
The transfer agent and registrar for the company's common stock is Odyssey Trust Company at its principal offices in Calgary, Alberta and Vancouver, British Columbia
DMCL Certified Public Accountants LLP.
Please submit your e-mail address on the "Email Alerts" section of this website.
Please submit investor questions by emailing us at: IR@Curaleaf.com.